# D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder

> **NCT00257361** · PHASE2 · WITHDRAWN · sponsor: **University of Florida**

## Conditions studied

- Obsessive Compulsive Disorder

## Interventions

- **DRUG:** D-Cycloserine

## Key facts

- **NCT ID:** NCT00257361
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI left the university
- **Last updated:** 2013-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00257361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00257361, "D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00257361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*